By BO LEUNG in London | CHINA DAILY | Updated: 2021-05-10 07:02 Share CLOSE A health worker checks a woman who received a dose of the China-made Sinopharm COVID-19 vaccine in Panadura, a suburb of Sri Lanka s capital, Colombo, on Saturday. ISHARA S. KODIKARA/AFP
The World Health Organization s approval to give emergency use to the COVID-19 vaccine manufactured by China s Sinopharm has been welcomed by experts and health regulators worldwide.
On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to be rolled out globally to reach countries in need and boost WHO-backed efforts such as the COVAX initiative.
A health worker checks a woman who received a dose of the China-made Sinopharm COVID-19 vaccine in Panadura, a suburb of Sri Lanka s capital, Colombo, on Saturday. ISHARA S. KODIKARA/AFP
BEIJING/LONDON, May 10 (China Daily/ANN): The World Health Organization s approval to give emergency use to the COVID-19 vaccine manufactured by China s Sinopharm has been welcomed by experts and health regulators worldwide.
On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to be rolled out globally to reach countries in need and boost WHO-backed efforts such as the COVAX initiative.
Source：
2021-05-10 17:44
A report published recently on British journal Nature noted that such certification by the WHO could help address the current shortfall in vaccines available through COVAX, and potentially opens the door to wide distribution in lower-income nations through the COVAX initiative.
GENEVA The World Health Organization (WHO) on Friday validated the COVID-19 vaccine developed by China s Sinopharm for emergency use, a move widely welcomed by officials and experts worldwide and set to benefit the global fight against the pandemic.
This is a great success and benefit for the world because the Sinopharm COVID-19 vaccine validated by the WHO is proving very effective in countries including Pakistan where it is being administered, said Musarrat Amin, a Pakistani strategic security analyst.
2021-05-08 11:36:04 GMT2021-05-08 19:36:04(Beijing Time) Xinhua English
by Naim-Ul-Karim
DHAKA, May 8 (Xinhua) The decision by the World Health Organization (WHO) to list China s Sinopharm vaccine for emergency use will bolster the inoculation drive against the ongoing COVID-19 pandemic worldwide, a Bangladeshi health expert said on Saturday.
Bangladesh is very pleased to learn about the WHO decision to include the Chinese-made vaccine in the Emergency Use Listing (EUL), which surely comes as a big blessing for the whole world in the fight against the deadly disease, said Mushtuq Hossain, an adviser to the Institute of Epidemiology, Disease Control and Research under Bangladesh s Health Ministry, in an interview with Xinhua.
Last Updated:
Bangladesh Likely To Extend Lockdown For Another Week, Meeting Over COVID-19 On April 19
Amid the surge in COVID-19 cases, the Bangladesh government is likely to extend lockdown in the country. The meeting over COVID-19 pandemic on April 19.
(Image Credits: AP)
The COVID-19 pandemic continues to create havoc in Bangladesh as 102 deaths were recorded due to the novel virus in the past 24 hours. Amid the surge in COVID-19 cases, the Bangladesh government is likely to extend the lockdown in the country for another week, ANI quoted Minister for Public Administer Farhad Hossain as saying to Dhaka Tribune.
Lockdown in Bangladesh